Salvage chemotherapy with CPT-11 for recurrent meningioma.

Journal of Neuro-oncology
Marc C ChamberlainSusan Groshen

Abstract

A prospective Phase II study of irinotecan (CPT-11) in adult patients with recurrent surgery and radiotherapy-refractory WHO Grade I meningioma. Sixteen patients (5 men; 11 women) ages 48-70 years (median 62.5), with recurrent meningioma were treated. All patients had previously been treated with surgery (complete in 4; partial in 9; biopsy in 3) and involved-field radiotherapy (median dose 54 Gy; 12 following first surgery and 4 following second surgery). Additionally, eight patients underwent re-operation (complete in 2; partial in 6) and eight patients were treated with salvage stereotactic radiosurgery. No patient was treated with prior chemotherapy. CPT-11 was administered intravenously every 3 weeks (350 mg/m2/day in patients on non-enzyme inducing anticonvulsants [NEIAED]; 600 mg/m2/day in patients on enzyme-inducing anticonvulsants [EIAED]) for 9 weeks (operationally defined as a single cycle). Neurological and neuroradiographic evaluation were performed every 10 weeks. All patients were evaluable. A median of two cycles of CPT-11 (range 1-4) was administered. CPT-11 related-toxicity (> or = grade 3) included diarrhea (6 occurrences, 19% all cycles administered), granulocytopenia (6, 19%), leukopenia (5, 16%), thrombocy...Continue Reading

References

Jun 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·S W LambertsH de Jong
Apr 1, 1991·Journal of Neurosurgery·D KondziolkaJ C Flickinger
Jun 1, 1991·Journal of Neurosurgery·S M GrunbergL L Stevenson
Feb 1, 1990·Journal of Neuro-oncology·S M Grunberg, M H Weiss
Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R MacdonaldJ G Cairncross
Oct 1, 1990·Journal of Neurosurgery·R P FirschingN Klug
Jan 1, 1985·Journal of Neurosurgery·R O MirimanoffR L Martuza
Feb 4, 1995·Lancet·C Wöber-BingölD Prayer
May 1, 1996·Journal of Neurosurgery·M C Chamberlain
Sep 1, 1996·Journal of Neuro-oncology·M Bondy, B L Ligon
Sep 1, 1996·Journal of Neuro-oncology·A P Kyritsis
May 1, 1997·Neurology·J B Braunstein, N A Vick
Feb 24, 2001·Journal of Neuro-oncology·H B NewtonC Stevens
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roger StuppSerge Leyvraz
Jul 24, 2002·Journal of Neurosurgery·John Y K LeeL Dade Lunsford
Jun 6, 2003·International Journal of Radiation Oncology, Biology, Physics·John C FlickingerL Dade Lunsford

❮ Previous
Next ❯

Citations

Jan 22, 2009·Current Opinion in Neurology·Helmut Wilhelm
Nov 3, 2006·Expert Review of Neurotherapeutics·Patrick Y Wen, Jan Drappatz
Oct 23, 2012·Expert Review of Neurotherapeutics·W J Sherman, J J Raizer
Sep 23, 2011·Journal of Neuro-oncology·David A ReardonHenry S Friedman
Oct 27, 2007·Neurosurgical Focus·Jason RockhillMarc C Chamberlain
Oct 27, 2007·Neurosurgical Focus·Andrew D NordenPatrick Y Wen
Mar 21, 2007·Journal of Neurosurgery·Vinay GuptaThomas C Chen
Apr 3, 2018·Neurosurgical Focus·Saksham GuptaIan F Dunn
Jul 13, 2007·Journal of Neuro-oncology·Mahlon D JohnsonSteven A Toms
Jun 30, 2009·Journal of Neuro-oncology·Andrew D NordenPatrick Y Wen
Oct 1, 2011·Expert Review of Neurotherapeutics·Marc C Chamberlain, Jill S Barnholtz-Sloan
Mar 1, 2013·CNS Oncology·Wendy J Sherman, Jeff J Raizer
Sep 27, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Constantin A DasanuJuliana Alvarez-Argote
Jun 27, 2008·Current Treatment Options in Neurology·Sean Grimm, Jeffrey J Raizer
Sep 16, 2010·Current Treatment Options in Neurology·Jeffrey Raizer
Jul 5, 2012·Current Opinion in Oncology·Marc C Chamberlain
Dec 3, 2013·Neurosurgical Focus·Alan A MoazzamGabriel Zada
Nov 5, 2013·Current Opinion in Neurology·Matthias PreusserAndreas F Hottinger
Nov 22, 2008·Journal of Neuro-oncology·Chrissa Sioka, Athanassios P Kyritsis
Mar 17, 2010·Journal of Neurosurgery·Michael E SughrueMichael W McDermott
Apr 27, 2012·Journal of Neuro-oncology·Emil LouDavid A Reardon
Jan 15, 2014·Rare Tumors·Vinay GuptaSteven I Robinson
Apr 29, 2016·Expert Review of Neurotherapeutics·E Le RhunM C Chamberlain
Aug 8, 2018·Future Oncology·Robin A BuerkiRimas V Lukas
Sep 9, 2010·Cancer·Austin MattoxCory Adamson
Sep 8, 2010·Journal of Neuro-oncology·Patrick Y WenAndrew D Norden
Jan 23, 2014·Journal of Neuro-oncology·Jeffrey J RaizerMarc Chamberlain
Apr 29, 2009·Acta neurochirurgica·M BehbahaniL M Alakandy
Apr 8, 2009·Current Neurology and Neuroscience Reports·Andrew D NordenPatrick Y Wen
Aug 8, 2018·Biomedicines·Fares NigimYasin Temel
Feb 15, 2011·Journal of Neuro-oncology·Marc C Chamberlain, Sandra K Johnston
May 4, 2011·Current Treatment Options in Oncology·Zanetta Lamar, Glenn J Lesser
Dec 18, 2018·Expert Opinion on Biological Therapy·Constantin A DasanuIon Codreanu
Oct 13, 2020·Frontiers in Oncology·Zhiwei ShaoJianmin Zhang
Dec 18, 2020·Frontiers in Oncology·Taylor Anne WilsonWarren Boling

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.